QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Leducq, N. Articles by Herbert, J.-M. Search for Related Content PubMed PubMed Citation Articles by Leducq, N. Articles by Herbert, J.-M.

CARDIOVASCULAR

Role of Peripheral Benzodiazepine Receptors in Mitochondrial, Cellular, and Cardiac Damage Induced by Oxidative Stress and Ischemia-Reperfusion

Sanofi Synthélabo Research, Toulouse and Chilly-Mazarin, France

Mitochondrial dysfunction has been identified as a possible early event in ischemia-reperfusion damage. The peripheral benzodiazepine receptor, a mitochondrial inner membrane protein, has already been proposed to play a role in mitochondrial regulation, although its exact function remains unclear. The aim of this work was to determine the role of peripheral benzodiazepine receptor in ischemia-reperfusion injury and to test the potential beneficial effect of a novel potent peripheral benzodiazepine receptor ligand, 7-chloro-N,N,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-acetamide (SSR180575). To characterize and link the mitochondrial, cellular, and cardiac consequences of ischemia-reperfusion, we examined the effects of SSR180575 in several in vitro and in vivo models of oxidative stress. Hydrogen peroxide decreased mitochondrial membrane potential, reduced oxidative phosphorylation capacities, and caused cytochrome c release, caspase 3 activation, and DNA fragmentation. SSR180575 (100 nM-1 µM) prevented all these effects. In perfused rat hearts, SSR180575 administered in vitro (100 nM-1 µM) or by oral pretreatment (3-30 mg/kg) greatly reduced the contractile dysfunction associated with ischemia-reperfusion. Furthermore, in anesthetized rats, SSR180575 (3-30 mg/kg p.o.) produced significant reductions in infarct size after coronary artery occlusion/reperfusion. In conclusion, we have demonstrated that peripheral benzodiazepine receptor play a major role in the regulation of cardiac ischemia-reperfusion injury and that SSR180575, a novel peripheral benzodiazepine receptor ligand, is of potential interest in these indications.

Address correspondence to: Dr. J. M. Herbert, Cardiovascular-Thrombosis Research Department, Sanofi-Synthélabo Research, 195, Route d'Espagne, 31036 Toulouse, France. E-mail: jean-marc.herbert{at}sanofi-synthelabo.com

This article has been cited by other articles:

				D. A. Brown, M. A. Aon, F. G. Akar, T. Liu, N. Sorarrain, and B. O'Rourke Effects of 4'-chlorodiazepam on cellular excitation-contraction coupling and ischaemia-reperfusion injury in rabbit heart Cardiovasc Res, July 1, 2008; 79(1): 141 - 149. [Abstract] [Full Text] [PDF]

				F. N. Obame, R. Zini, R. Souktani, A. Berdeaux, and D. Morin Peripheral Benzodiazepine Receptor-Induced Myocardial Protection is Mediated by Inhibition of Mitochondrial Membrane Permeabilization J. Pharmacol. Exp. Ther., October 1, 2007; 323(1): 336 - 345. [Abstract] [Full Text] [PDF]

				O. R. Kunduzova, G. Escourrou, F. De La Farge, R. Salvayre, M.-H. Seguelas, N. Leducq, F. Bono, J.-M. Herbert, and A. Parini Involvement of Peripheral Benzodiazepine Receptor in the Oxidative Stress, Death-Signaling Pathways, and Renal Injury Induced by Ischemia-Reperfusion J. Am. Soc. Nephrol., August 1, 2004; 15(8): 2152 - 2160. [Abstract] [Full Text] [PDF]